2017 American Transplant Congress
The New Kidney Allocation System: The Effect on Elderly Transplantation in the US. Review of UNOS Database.
Surgery, State University New York, Syracuse, NY
The New Kidney Allocation System(KAS) improve access disadvantaged groups. The effect on the elderly population, recipients >=65 is unknown.Methods: Retrospective analysis of UNOS database preKAS…2017 American Transplant Congress
Association with Tacrolimus Intraindividual Variability, Acute Microinflammation Based on 1 Year-Transplanted Kidney Biopsy After Transplantation, and Biopsy-Proven Acute Rejection.
Surgery, Seoul National University College of Medicine, Seoul, Korea
Background: The purpose of this study was to investigate relationship between tacrolimus intraindividual variability (IIV), acute microinflammation (AMI) based on 1 year-transplanted kidney biopsy, and…2017 American Transplant Congress
Incidence of De Novo Donor-Specific Antibodies Following Kidney Transplantation.
With a range of frequencies reported in several small studies, true incidence of de novo donor-specific human leukocyte antigen (HLA) antibodies (dnDSA) is unknown. As…2017 American Transplant Congress
Pre-Transplant Circulating TNFR2+ Regulatory T Cells Predict Acute Rejection within the First 6 Months After Kidney Transplantation.
Background: Acute rejection (AR) mostly occurs during the first 6 months after kidney transplantation and contributes importantly to graft loss. Diagnosis relies on changes in…2017 American Transplant Congress
Ambulatory Antibiotic Utilization and Outcomes in an Adult Kidney Transplant Population: A Pharmacovigilance Analysis.
Pharmacy, Ralph H Johnson VAMC, Charleston, SC
Antibiotics (abx) are commonly prescribed to kidney transplant (KTX) recipients in the outpatient setting. There is limited data assessing the safety and outcomes associated with…2017 American Transplant Congress
Treating Ischemically Damaged Porcine Kidneys with Mesenchymal Stromal Cells During Normothermic Machine Perfusion.
Normothermic machine perfusion (NMP) could provide superior organ preservation and offers the unique opportunity for interventions to an isolated kidney prior to transplantation. There is…2017 American Transplant Congress
Analysis of Differences in Living Donor and Recipient Pairs Estimated GFR at Six Months Over Time.
Medicine, Division of Nephrology, Sacred Heart Hospital, Pensacola, FL
Previous studies of the United States Kidney Transplant Database revealed that the median estimated GFR (eGFR) has improved over the last decade for living donor…2017 American Transplant Congress
Experience with Obinutuzumab (Type II Anti-CD20) in Kidney Transplant Patients with Donor Specific Antibody (DSA+) Antibody Mediated Rejection.
Comprehensive Transplant Center, Cedars-Sinai Medical Center, Los Angeles, CA
Introduciton:Rituximab is a type I chimeric IgG1 anti-CD20 antibody that has revolutionized the management and treatment of B-cell malignancies, and numerous autoimmune diseases. In addition,…2017 American Transplant Congress
Five-Year Outcomes After Transplantation of Kidneys from Deceased Donors with Acute Kidney Injury.
Background: Kidneys from deceased donors with acute kidney injury (AKI) are often discarded due to a perceived higher risk of poor graft function. Kidney Donor…2017 American Transplant Congress
Impact of Type of Recipient Diabetes on 1 and 3-Year Kidney Allograft and Patient Outcomes.
University of Michigan, Ann Arbor
The pathophysiology of type 1 (T1DM) and type 2 (T2DM) diabetes is different and has been conjectured to impact transplantation outcomes differently over time especially…
- « Previous Page
- 1
- …
- 360
- 361
- 362
- 363
- 364
- …
- 531
- Next Page »